Skip to main content
. 2022 May 24;54(6):e14483. doi: 10.1111/and.14483

TABLE 4.

Comparison of the IVF outcomes in vaccine and control group

Outcomes Vaccine group (n = 105) Control group (n = 155) p Value
No. of oocytes retrieved 14.74 ± 5.99 13.30 ± 5.82 0.053
No. of MII oocytes 11.67 ± 4.87 10.54 ± 5.05 0.073
No. of 2PN cleavage‐stage embryos 8.59 ± 4.47 7.75 ± 4.14 0.120
No. of blastocysts 5.06 ± 3.17 4.34 ± 3.06 0.067
No. of good‐quality blastocysts 2.08 ± 1.79 1.74 ± 1.54 0.103
High‐quality blastocyst rate 41.05% (218/531) 40.03% (269/672) 0.719
Fresh ET cycles 61 101
No. of embryos transferred 1.03 ± 0.18 1.08 ± 0.27 0.192
Biochemical pregnancy rate, % 68.85% (42/61) 59.41% (60/101) 0.228
Clinical pregnancy rate, % 55.74% (34/61) 45.54% (46/101) 0.209
Frozen ET cycles 69 118
No. of embryos transferred 1.61 ± 0.49 1.73 ± 0.45 0.098
Biochemical pregnancy rate, % 63.77% (44/69) 65.25% (77/118) 0.963
Clinical pregnancy rate, % 42.03% (29/69) 41.53% (49/118) 0.946

Abbreviations: ET, embryo transfer; MII, metaphase II; 2PN, two pronucleus.